E-vita open plus Stent Graft System - Graft, vascular, synthetic

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Disponible depuis:

Cryolife Medical (Australia) Company Pty Ltd

classe:

Class III

Fabriqué par:

Jotec GmbH Lotzenacker 23, Hechingen, 72379 Germany

Domaine thérapeutique:

35281 - Graft, vascular, synthetic

indications thérapeutiques:

The E-vita open plus delivery system with loaded stentgraft is introduced into the aorta through a median sternotomy using a guide wire and advanced up to the implantation site.The self-expanding mechanism of the E-vita open plus stentgraft is triggered by retracting the outer shell of the delivery system.The stentgraft adapts itself to the shape and size of the sealing zone. The E-vita open plus Stent Graft System is indicated for the treatment of aneurysms, dissections and specific lesions of the thoracic aorta.

Statut de autorisation:

A

Date de l'autorisation:

2013-11-04